HCM
MRNA icon

Hodges Capital Management’s Moderna MRNA Stock Holding History

Hodges Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,358
Closed -$1.52M – 175
2023
Q1 		$1.51M Sell
11,358
-34,404
-75% -$5.68M 0.12% 139
2022
Q4 		$8.22M Buy
45,762
+38,762
+554% +$6.34M 0.71% 44
2022
Q3 		$828K Sell
7,000
-950
-12% -$144K 0.14% 128
2022
Q2 		$1.14M Sell
7,950
-1,850
-19% -$264K 0.11% 127
2022
Q1 		$7.27M Sell
9,800
-26,675
-73% -$4.49M 0.58% 63
2021
Q4 		$9.26M Sell
36,475
-38,875
-52% -$11.4M 0.67% 53
2021
Q3 		$29M Buy
75,350
+22,350
+42% +$8.24M 2.13% 7
2021
Q2 		$12.5M Buy
+53,000
New +$9.47M 1.4% 15

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hodges Capital Management's MRNA Position: Q2 2023 in Review

Hodges Capital Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 11,358 shares — an estimated $1.52M sold.

Hodges Capital Management first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $29M in Q3 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Hodges Capital Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Hodges Capital Management sold 11,358 Moderna shares in Q2 2023, an estimated $1.52M.
  • Hodges Capital Management first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • Hodges Capital Management's Moderna position peaked at $29M in Q3 2021.
  • 967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Hodges Capital Management's 13F filing for Q2 2023, filed 7 Aug 2023.